Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study

BACKGROUND AND OBJECTIVE: Prescribing inhaled corticosteroids (ICS) for bronchiectasis (BE) in the absence of obstructive lung disease is controversial. Studies investigating ICS therapy and impact on morbidity and mortality in BE are sparse. METHODS: This study comprises all patients with BE manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Håkansson, Kjell E J, Fjaellegaard, Katrine, Browatzki, Andrea, Dönmez Sin, Melda, Ulrik, Charlotte Suppli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291380/
https://www.ncbi.nlm.nih.gov/pubmed/34295156
http://dx.doi.org/10.2147/COPD.S311236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291380/
https://www.ncbi.nlm.nih.gov/pubmed/34295156
http://dx.doi.org/10.2147/COPD.S311236

Ejemplares similares